(i) What would happen to Mylan's revenue? If Mylan is required to make its price uniform for all countries, its revenue is likely to decrease. This is because the price of EpiPen is much higher in the US than in other countries. If Mylan is required to lower its price in the US to match the prices in other countries, its overall revenue will decline. (ii) What would happen to the access to EpiPen in countries outside the US? If Mylan is required to make its price uniform for all countries, access to EpiPen in countries outside the US is likely to increase. This is because Mylan would be able to sell EpiPen in more countries at a lower price. This would make EpiPen more affordable for people in countries where it is currently very expensive